Epinex Diagnostics, Inc.
Epinex Diagnostics, Inc. is a medical device company based in Tustin, California, United States. Established in 2002, the company specializes in developing innovative rapid tests addressing major gaps in the healthcare market. It offers unique quantitative diagnostic tests for point-of-care (POC) and over-the-counter (OTC) markets, utilizing a proprietary platform that leverages existing technologies. The company's flagship product is the G1A™ Rapid Diabetes Monitoring Index Test, a patented monthly test designed to revolutionize diabetes monitoring, which is a critical issue within the global healthcare landscape.
Located in close proximity to the University of California, Irvine, Epinex Diagnostics benefits from the bustling Southern California biomedical industry, fostering a conducive environment for innovation and collaboration.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Venture Round | $100.00K | - | 14 Feb 2016 | |
| Venture Round | $2.17M | - | 15 Jan 2016 | |
| Venture Round | $318.00K | - | 05 Mar 2013 | |
| Venture Round | $202.76K | - | 29 Apr 2011 | |
| Venture Round | $598.74K | - | 10 Aug 2010 |
No recent news or press coverage available for Epinex Diagnostics, Inc..
We care about your data, and we'd love to use cookies make your experience better.
